02250nas a2200325 4500000000100000000000100001008004100002260001500043653002100058653001700079100002500096700002200121700001800143700003300161700001800194700001900212700001600231700001400247700001800261700002400279700001800303700002100321700002000342245009400362856005500456300000900511490000600520520138400526022001401910 2024 d c2024-11-1810aAdult Stem Cells10aCell biology1 aAlessandro Cherubini1 aFrancesco Rusconi1 aRoberta Piras1 aKaja Nicole Wächtershäuser1 aMarta Dossena1 aMario Barilani1 aCecilia Mei1 aLotta Hof1 aValeria Sordi1 aFrancesco Pampaloni1 aVincenza Dolo1 aLorenzo Piemonti1 aLorenza Lazzari00aExploring human pancreatic organoid modelling through single-cell RNA sequencing analysis uhttps://www.nature.com/articles/s42003-024-07193-3 a1-160 v73 aHuman organoids have been proposed to be powerful tools mimicking the physiopathological processes of the organs of origin. Recently, human pancreatic organoids (hPOs) have gained increasing attention due to potential theragnostic and regenerative medicine applications. However, the cellular components of hPOs have not been defined precisely. In this work, we finely characterized these structures, focusing first on morphology and identity-defining molecular features under long-term culture conditions. Next, we focused our attention on hPOs cell type composition using single-cell RNA sequencing founding a complex heterogeneity in ductal components, ranging from progenitor components to terminally differentiated ducts. Furthermore, an extensive comparison of human pancreatic organoids with previously reported transcriptomics signature of human and mouse pancreatic ductal populations, confirmed the functional pancreatic duct subpopulation heterogeneity. Finally, we showed that pancreatic organoid cells follow a precise developmental trajectory and utilize diverse signalling mechanisms, including EGF and SPP1, to facilitate cell-cell communication and maturation. Together our results offer an in-depth description of human pancreatic organoids providing a strong foundation for future in vitro diagnostic and translational studies of pancreatic health and disease. a2399-3642